IL6 (Interleukin 6); Recombinant Human Protein
Product Image
Gibco™

IL6 (Interleukin 6); Recombinant Human Protein

Recombinant Human Interleukin 6 (IL6) is a bioactive protein intended for use in cell culture applications. IL6 is a pleotropicRead more
Have Questions?
Catalog NumberQuantity
CTP00631 mg
Catalog number CTP0063
Price (CLP)
8.346.878
1 mg
Add to cart
Quantity:
1 mg
Price (CLP)
8.346.878
1 mg
Add to cart
Recombinant Human Interleukin 6 (IL6) is a bioactive protein intended for use in cell culture applications. IL6 is a pleotropic cytokine involved in several cellular processes including inflammation, hematopoeisis, and immune response. The lyophilized, E. coli-expressed IL6 Recombinant Human is verified for activity through dose-dependent proliferation of mouse B9 cells.

Highly Pure—minimizes interference from other proteins or contaminants
Active—get more results with less protein

High Purity
To help verify that GIBCO™ Recombinant growth factors are of the highest quality, each protein is analyzed for purity, along with structural homogeneity, to help ensure a biologically active protein. The purity of each GIBCO™ recombinant growth factor is verified by SDS-PAGE to be over 95% pure and to have endotoxin levels below 0.1 ng/μg.

High Biological Activity
All GIBCO™ Recombinant growth factors are verified for activity. Each lot has its own ED50 determined using an activity assay based on a specific function of the growth factor. The activity of our IL6 Recombinant Human growth factor is determined by the dose-dependent proliferation of mouse B9 cells to have an ED50 range of 0.008–0.02 ng/mL (specific activity: 1.25 × 10^8–5.0 × 10^7 units/mg). Optimal concentration for individual applications should be determined by a dose response assay.

Related Links
Our Full Collection of GIBCO™ Growth Factors
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Activity0.008 ng/ml
BioassayProliferation of B9 cells
ClassificationCarrier-Free
Endotoxin Level<0.1 ng/μg
Expression SystemE. coli
Gene AliasIL-6 (Interleukin 6)
Molecular Weight (g/mol)21.3 kDa
Product LineGibco
Protein FamilyCytokines & Receptors
Protein FormFull Length, Recombinant, Ligand
Protein Length184 aa
Protein SubtypeInterleukins
Purification MethodSequential Chromatography
Purity or Quality Grade95 %
Quantity1 mg
Research CategoryClinical Research, Bone Research, Stem Cell Research, Immunology, Inflammation
Shipping ConditionWet Ice
SourceHuman
For Use With (Application)Cell Culture
FormLyophilized
RecombinantRecombinant
SpeciesHuman
Unit Size1 mg
Contents & Storage
2°C to 8°C

Frequently asked questions (FAQs)

It looks like the recombinant protein vial I received from you is empty. Is this normal?

Gibco recombinant proteins are frequently formulated without carrier proteins or additives (e.g., BSA, HSA, sucrose, etc.) and no Gibco PeproTech recombinant protein contains a carrier protein. As a result, during lyophilization, the protein product may be deposited on the vial as a thin, and sometimes invisible, film instead of a pellet. The size of the pellet, if any, is not directly related to the quantity of the recombinant protein in the vial. Our quality control procedures assure that each vial contains the correct amount of product.

To ensure complete recovery of protein product, before opening a vial of lyophilized recombinant protein, we recommend centrifuging it in a microcentrifuge for 20-30 seconds to drive any protein that may be lodged in the cap or on the side to the bottom of the vial. After reconstitution, you can confirm the presence of product protein by running a small amount on SDS-PAGE. In general, a protein band with expected size should be visible with as little as 10 ng of protein loaded on an acrylamide gel.

Find additional tips, troubleshooting help, and resources within our Cell Culture Support Center.

Why does my recombinant protein not show activity in my own experiment?

Assay time is critical. Each assay needs to beoptimized and performed at the peak response time. Different cells may respond differently to a growth factor or cytokine. We suggest repeating our QC assay using same indicator cells as suggested in the manual to see if you can obtain a similar response. In addition, serum may be masking the response. Serum starvation might be needed for certain types of assays.

How should I store the reconstituted recombinant proteins?

Protein solutions are generally not very stable when frozen at low concentration. Upon freeze and thaw, some proteins in the solution may stick to the wall of the container, which results in significant reduction of protein concentration if the starting concentration was low. Therefore, carrier proteins are used to reduce such loss. The most commonly used carrier proteins include bovine serum albumin (BSA), human serum albumin (HSA), or fetal bovine serum (FBS). These carrier proteins are generally used at 0.1% concentration. As a rule of thumb, if the concentration of the recombinant protein is less than 0.5 mg/mL, it is a good idea to add some carrier protein

How do I store my lyophilized recombinant protein?

Lyophilized proteins can typically be stored at 2 to 8 degrees C for several weeks, or stored dessicated at -20 degrees C for long-term storage.

Citations & References (6)

Citations & References
Abstract
Pleiotropic anti-myeloma activity of ITF2357: inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b.
Authors:Todoerti K, Barbui V, Pedrini O, Lionetti M, Fossati G, Mascagni P, Rambaldi A, Neri A, Introna M, Lombardi L, Golay J
Journal:Others
PubMed ID:19713220
'BACKGROUND: The histone deacetylase inhibitor ITF2357 has potent cytotoxic activity in multiple myeloma in vitro and has entered clinical trials for this disease. DESIGN AND METHODS: In order to gain an overall view of the activity of ITF2357 and identify specific pathways that may be modulated by the drug, ... More
IL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters.
Authors:Andrejko KM, Raj NR, Kim PK, Cereda M, Deutschman CS
Journal:Shock
PubMed ID:17724432
'Sepsis, a lethal inflammatory syndrome, is characterized by organ system dysfunction. In the liver, we have observed decreased expression of genes encoding proteins modulating key processes. These include organic anion and bile acid transport. We hypothesized that the inflammatory mediator IL-6 modulates altered expression of several key hepatic genes in ... More
Interleukin-1beta and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: a possible explanation for oxidative stress generation.
Authors:Mathy-Hartert M, Hogge L, Sanchez C, Deby-Dupont G, Crielaard JM, Henrotin Y
Journal:Osteoarthritis Cartilage
PubMed ID:18291685
Beside matrix metalloproteinases, reactive oxygen species (ROS) are the main biochemical factors of cartilage degradation. To prevent ROS toxicity, chondrocytes possess a well-coordinated enzymatic antioxidant system formed principally by superoxide dismutases (SODs), catalase (CAT) and glutathione peroxidase (GPX). This work was designed to assess the effects of interleukin (IL)-1beta and ... More
IL-4 amplifies the pro-inflammatory effect of adenosine in human mast cells by changing expression levels of adenosine receptors.
Authors:Hua X, Chason KD, Patel JY, Naselsky WC, Tilley SL,
Journal:PLoS One
PubMed ID:21966389
Adenosine inhalation produces immediate bronchoconstriction in asthmatics but not in normal subjects. The bronchospastic effect of adenosine is largely mediated through adenosine-induced mast cell activation, the mechanism of which is poorly understood due to limitations in culturing human primary mast cells. Here, we show that human umbilical cord blood -derived ... More
Control of gluconeogenic genes during intense/prolonged exercise: hormone-independent effect of muscle-derived IL-6 on hepatic tissue and PEPCK mRNA.
Authors:Banzet S, Koulmann N, Simler N, Sanchez H, Chapot R, Serrurier B, Peinnequin A, Bigard X
Journal:J Appl Physiol
PubMed ID:19850730
Prolonged intense exercise is challenging for the liver to maintain plasma glucose levels. Hormonal changes cannot fully account for exercise-induced hepatic glucose production (HGP). Contracting skeletal muscles release interleukin-6 (IL-6), a cytokine able to increase endogenous glucose production during exercise. However, whether this is attributable to a direct effect of ... More